ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,126Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 586

$458K Total Retail Price of All Prescriptions

Rank: 34 out of 586

555 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 555 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 555 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

4% of this provider’s 7,378 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
SIMVASTATIN 409 352 1 1
HYDROCODONE-ACETAMINOPHEN 349 269 S3 2 5
OMEPRAZOLE 322 272 3 3
LEVOTHYROXINE SODIUM 302 268 4 2
METFORMIN HCL 292 254 5 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 239 203 6 16
FUROSEMIDE 206 174 7 9
AZITHROMYCIN 190 140 8 36
HYDROCHLOROTHIAZIDE 186 171 9 10
LISINOPRIL 182 169 10 4
SERTRALINE HCL 159 139 11 21
AMLODIPINE BESYLATE 158 146 12 7
TRAMADOL HCL 143 95 13 15
GLIMEPIRIDE 138 120 14 38
ZOLPIDEM TARTRATE 132 120 15 8
TRAZODONE HCL 124 88 16 20
ALLOPURINOL 120 86 17 35
POTASSIUM CHLORIDE 114 104 18 14
PREDNISONE 114 90 18 56
SYNTHROID 112 106 20 45
WARFARIN SODIUM 111 102 21 13
GABAPENTIN 105 94 22 11
FLUOXETINE HCL 103 47 23 24
PROAIR HFA 92 57 24 58
OXYCODONE HCL 87 37 S2 25 32
METOPROLOL TARTRATE 84 77 26 26
IBUPROFEN 80 48 27 43
JANUVIA 76 64 28 74
OXYCODONE HCL-ACETAMINOPHEN 73 56 S2 29 55
PANTOPRAZOLE SODIUM 72 72 30 68
FINASTERIDE 72 67 30 84
OXYCODONE-ACETAMINOPHEN 71 54 S2 32 78
METOPROLOL SUCCINATE 70 65 33 19
GLYBURIDE 69 69 R 34 101
ATORVASTATIN CALCIUM 68 57 35 17
CELEBREX 68 68 35 44
DICLOFENAC SODIUM 68 55 35 85
PREMARIN 67 53 R 38 125
ACETAMINOPHEN-CODEINE 59 42 S3 39 184
LOSARTAN POTASSIUM 59 52 39 18
CITALOPRAM HBR 57 57 41 12
TAMSULOSIN HCL 57 53 41 27
CARISOPRODOL 55 0 R 43 57
RANITIDINE HCL 55 55 43 61
CIPROFLOXACIN HCL 53 46 45 82
ESTRADIOL 51 46 R 46 66
CRESTOR 50 37 47 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 14, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.